Literature DB >> 24998582

Association between pancreatitis and subsequent risk of pancreatic cancer: a systematic review of epidemiological studies.

Gui-Xian Tong1, Qing-Qing Geng, Jing Chai, Jing Cheng, Peng-Lai Chen, Han Liang, Xing-Rong Shen, De-Bin Wang.   

Abstract

This study aimed to summarize published epidemiological evidence for the relationship between pancreatitis and subsequent risk of pancreatic cancer (PC). We searched Medline and Embase for epidemiological studies published by February 5th, 2014 examining the risk of PC in pancreatitis patients using highly inclusive algorithms. Information about first author, year of publication, country of study, recruitment period, type of pancreatitis, study design, sample size, source of controls and attained age of subjects were extracted by two researchers and Stata 11.0 was used to perform the statistical analyses and examine publication bias. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated with the random effects model. A total of 17 articles documenting 3 cohort and 14 case-control studies containing 14,667 PC cases and 17,587 pancreatitis cases were included in this study. The pooled OR between pancreatitis and PC risk was 7.05 (95%CI: 6.42-7.75). However, the pooled ORs of case-control and cohort studies were 4.62 (95%CI: 4.08-5.22) and 16.3 (95%CI: 14.3-18.6) respectively. The risk of PC was the highest in patients with chronic pancreatitis (pooled OR=10.35; 95%CI: 9.13-11.75), followed by unspecified type of pancreatitis (pooled OR=6.41; 95%CI: 4.93-8.34), both acute and chronic pancreatitis (pooled OR=6.13; 95%CI: 5.00-7.52), and acute pancreatitis (pooled OR=2.12; 95%CI: 1.59-2.83). The pooled OR of PC in pancreatitis cases diagnosed within 1 year was the highest (pooled OR=23.3; 95%CI: 14.0-38.9); and the risk in subjects diagnosed with pancreatitis for no less than 2, 5 and 10 years were 3.03 (95%CI: 2.41-3.81), 2.82 (95%CI: 2.12-3.76) and 2.25 (95%CI: 1.59-3.19) respectively. Pancreatitis, especially chronic pancreatitis, was associated with a significantly increased risk of PC; and the risk decreased with increasing duration since diagnosis of pancreatitis.

Entities:  

Mesh:

Year:  2014        PMID: 24998582     DOI: 10.7314/apjcp.2014.15.12.5029

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  12 in total

Review 1.  Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency.

Authors:  Lesley J Scott
Journal:  Drugs       Date:  2015-02       Impact factor: 9.546

2.  The Risk Factors for Progression to Chronic Pancreatitis in Patients with Past-History of Acute Pancreatitis: A Retrospective Analysis Based on Mechanistic Definition.

Authors:  Akira Yamamiya; Keiichi Tominaga; Koki Hoshi; Kazunori Nagashima; Takahito Minaguchi; Yasuo Haruyama; Atsushi Irisawa
Journal:  J Clin Med       Date:  2022-04-15       Impact factor: 4.964

Review 3.  Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis.

Authors:  Jakob Kirkegård; Frank Viborg Mortensen; Deirdre Cronin-Fenton
Journal:  Am J Gastroenterol       Date:  2017-08-01       Impact factor: 10.864

Review 4.  Obesity and Pancreatic Cancer: Overview of Epidemiology and Potential Prevention by Weight Loss.

Authors:  Mu Xu; Xiaoman Jung; O Joe Hines; Guido Eibl; Yijun Chen
Journal:  Pancreas       Date:  2018-02       Impact factor: 3.327

Review 5.  Serum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis.

Authors:  Yuanfeng Gong; Bingyi Zhang; Yadi Liao; Yunqiang Tang; Cong Mai; Tiejun Chen; Hui Tang
Journal:  Nutrients       Date:  2017-04-18       Impact factor: 5.717

6.  Chronic pancreatitis and cancer risk in a matched cohort study using national claims data in South Korea.

Authors:  Minji Han; Thi Phuong Thao Tran; Jin-Kyoung Oh
Journal:  Sci Rep       Date:  2022-04-01       Impact factor: 4.379

7.  Chronic Pancreatitis Is a Risk Factor for Pancreatic Cancer, and Incidence Increases With Duration of Disease: A Systematic Review and Meta-analysis.

Authors:  Sonal Gandhi; Jaime de la Fuente; Mohammad Hassan Murad; Shounak Majumder
Journal:  Clin Transl Gastroenterol       Date:  2022-03-28       Impact factor: 4.396

8.  The association of Helicobacter pylori with pancreatic cancer.

Authors:  Shria Kumar; David C Metz; David E Kaplan; David S Goldberg
Journal:  GastroHep       Date:  2020-05-05

9.  A novel scoring system to analyze combined effect of lifestyle factors on pancreatic cancer risk: a retrospective case-control study.

Authors:  Tianshu Pang; Guoping Ding; Zhengrong Wu; Guixing Jiang; Yifei Yang; Xiaofei Zhang; Liping Cao
Journal:  Sci Rep       Date:  2017-10-20       Impact factor: 4.379

10.  Expression of Smo in pancreatic cancer CD44+CD24+cells and construction of a lentiviral expression vector to silence Smo.

Authors:  Peng Cong; Chao Yi; Xi-Yan Wang
Journal:  Oncol Lett       Date:  2018-08-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.